abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2007년 4월 26일

저자:
Lisa Sachs, public health & law intern, Interfaith Center on Corporate Responsibility

[PDF] Human Rights Challenges Facing Abbott Laboratories: Risks and recommendations

Abbott has been criticized by consumers, investors, medical professionals, human rights activists, and governments for failing to ensure universal access to essential medicines, thereby violating the universal right to health. This memo focuses on Abbott’s responsibility with respect to the universal right to health and how Abbott has addressed, is addressing and should address this universal human right.